H19 expression is upregulated in the serum and bone marrow mesenchymal stem cells of SLE patients and positively correlated with SLE disease activity, and thus may regulate bone marrow mesenchymal stem cell-mediated T follicular helper/regulatory T lymphocyte cell balance by inhibiting IL-2 transcription (91). This evidence concerns the gene H19 and systemic lupus erythematosus.